TY  - JOUR
AU  - Romero, Alejandro
AU  - Ramos, Eva
AU  - Lopez-Muñoz, Francisco
AU  - Gil-Martin, Emilio
AU  - Escames, Germaine
AU  - Reiter, Russel J
PY  - 2020
DO  - 10.1007/s10571-020-00938-8
UR  - http://hdl.handle.net/10668/16074
T2  - Cellular and molecular neurobiology
AB  - The world faces an exceptional new public health concern caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), subsequently termed the coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO). Although the...
LA  - en
PB  - Springer New York LLC
KW  - COVID-19
KW  - Central nervous system
KW  - Melatonin
KW  - Neuroinvasion
KW  - Neuroprotection
KW  - SARS-CoV-2
KW  - Animals
KW  - Brain
KW  - COVID-19
KW  - Central Nervous System
KW  - Central Nervous System Agents
KW  - Central Nervous System Viral Diseases
KW  - Humans
KW  - Melatonin
KW  - Neuroprotective Agents
KW  - SARS-CoV-2
KW  - COVID-19 Drug Treatment
TI  - Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
TY  - research article
VL  - 42
ER  -